Here, we found that LC3 expression is significantly correlated with mild clinicopathological features, including macrovascular involvement, lymph node metastasis, AJCC stage, BCLC stage, recurrence, and mortality in cHCC-CC patients. Here, MAP1LC3A is linked to metastatic malignant neoplasm in the lymph nodes.